2017
Jens Lundgren
Researcher Who Has Prevented the Spread of Aids Receives the Hagedorn Prize
Jens Lundgren is receiving the 2017 Hagedorn Prize for his pioneering and internationally recognized research on treatment for people living with HIV.
Download image
Press photo
About Jens Lundgren
Jens Lundgren
Professor
- Senior Consultant, Department of Infectious Diseases, Rigshospitalet, Copenhagen
- Professor of Viral Diseases, University of Copenhagen
- Founder and Director of the Centre of Excellence for Health, Immunity and Infections (CHIP), which has led numerous pioneering studies on the treatment of people living with HIV and their risk of transmission.
- Jens Lundgren has led comprehensive global studies such as the Data Collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study, which demonstrated that antiretroviral therapy can increase the risk of heart attacks; the SMART study, which showed that interrupting anti-HIV treatment increases the risk of disease and death among people living with HIV; and the PARTNER study, which documented that people living with HIV receiving treatment do not transmit HIV through sexual contact.
- CHIP’s extensive knowledge on immunodeficiency is also used to investigate other conditions in which the immune system is compromised, such as transplantation and chemotherapy. Jens Lundgren recently established PERSIMUNE (Centre of Excellence for Personalized Medicine of Infectious Complications in Immune Deficiency) to examine the biological mechanisms that improve or worsen the condition of a person with a compromised immune system.